Session Type
Meeting
Search Results for Buprenorphine
Oral Presentations
Hospital Medicine 2019, March 24-27, National Harbor, Md.
Background: Despite a public health crisis – over 500,000 individuals have died from opioid overdoses since 2000 – and the availability of effective therapies, most patients with Opioid Use Disorder (OUD) are not offered treatment. Medication-Assisted Treatment (MAT), such as with buprenorphine, is associated with significantly higher rates of abstinence and follow-up, lower rates of […]
Oral Presentations
Abstract Number: Oral
SHM Converge 2021
Background: Despite evidence that the use of medications for patients with opioid use disorder (OUD) leads to reduced mortality and improved engagement in outpatient addiction treatment, these life-saving medications are underutilized in the hospital setting. This study reports the outcomes of a hospitalist-led interprofessional and multidisciplinary inpatient program, known as the B-Team (buprenorphine team), to […]
Oral Presentations
Hospital Medicine 2019, March 24-27, National Harbor, Md.
Background: Despite a public health crisis – over 500,000 individuals have died from opioid overdoses since 2000 – and the availability of effective therapies, most patients with Opioid Use Disorder (OUD) are not offered treatment. Medication-Assisted Treatment (MAT), such as with buprenorphine, is associated with significantly higher rates of abstinence and follow-up, lower rates of […]
Abstract Number: 83
Hospital Medicine 2020, Virtual Competition
Background: The US has a heavy burden of deaths from opioid overdoses, and New Mexico is not excepted from this. Treatment options for opioid use disorder (OUD) are buprenorphine/naloxone (“Suboxone”), methadone, naltrexone, counseling, and/or behavioral therapy. Long-acting oral opioids like Suboxone, are the most effective methods for treating opioid withdrawal and OUD. They are often […]
Abstract Number: 138
Hospital Medicine 2020, Virtual Competition
Background: Persons with opioid use disorders (OUD) represent a disproportionately high percentage of hospitalized patients, have greater lengths of stay and readmissions, can incur higher costs, and are at greater risk of drug-related death immediately post-discharge. Further, despite the availability of effective medications for OUD, patients often are not offered treatment during the inpatient encounter. […]
Abstract Number: 275
SHM Converge 2023
Background: In 2021 there were over 80,000 opioid overdose deaths. Studies show that inpatient hospitalizations are a vital moment in treating patients with opioid use disorder (OUD). Initiation of opioid agonist therapy (OAT: buprenorphine or methadone) is associated with a profound mortality benefit, with some studies suggesting a number needed to treat of less than […]
Abstract Number: 293
SHM Converge 2021
Background: Opioid use disorder (OUD) is a chronic relapsing disease that has become an epidemic in the United States. Overdoses of prescription and illicit opioids have killed almost 450,000 Americans between 1999-2018 (1). Guidelines on OUD management recommend, in combination with behavioral therapy, opioid agonist therapy as the first-line treatment option with antagonist therapy as an alternative option. OUD-related inpatient admissions represent […]
Abstract Number: 340
SHM Converge 2023
Background: Published work applying game theory to physician-patient interactions is nearly non-existent [1-4]. The most prominent work is the example of an emergency medicine physician being asked to prescribe opiates for a patient they suspect of opiate use disorder (OUD) seeking opiates for secondary gain (McAdams 2014). McAdams’ game theory analysis suggested that institutional pressure […]
Abstract Number: 344
SHM Converge 2023
Background: America is facing an opioid epidemic. From 1997 to 2017 there were 702,000 deaths from drug overdoses of which greater than 50% were from opioids. The opioid epidemic knows no boundaries, it affects men and women of all age groups and socioeconomic status. Hospitalists are now seeing more opioid related hospital admissions which have […]
Abstract Number: 358
SHM Converge 2023
Background: The incidence of Opioid Use Disorder (OUD) is rising around the world with nearly 27 million people living with OUD globally and over 100,000 opioid overdose deaths each year. The Society of Hospital Medicine recently released a consensus statement for management of patients with OUD admitted to the hospital. This statement included recommendations for […]